Ishares Trust · net assets $3.56B · 103 holdings as of July 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 99.1% · STIV: 0.9% · DE: 0.0%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $253M | $209M | $492M |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $18.5M | $352M | $151M |
| Net realized gain (non-derivative) | $1.33M | $57.1M | $32.8M |
| Net unrealized appreciation (non-derivative) | $75.5M | $134M | $24.5M |
The three months of the reporting period, as filed; month 3 ends July 31, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Eli Lilly And Company EC | $538M | 15.11% |
| Johnson & Johnson EC | $363M | 10.17% |
| Abbvie Inc. EC | $261M | 7.32% |
| Unitedhealth Group Incorporated EC | $220M | 6.16% |
| Merck & Co., Inc. EC | $189M | 5.31% |
| Thermo Fisher Scientific Incorporated EC | $125M | 3.52% |
| Amgen Inc. EC | $122M | 3.42% |
| Abbott Laboratories EC | $107M | 3.02% |
| Gilead Sciences, Inc. EC | $94.9M | 2.66% |
| Pfizer Inc. EC | $83.6M | 2.35% |
| Bristol-myers Squibb Company EC | $78.3M | 2.20% |
| Intuitive Surgical, Inc. EC | $73.1M | 2.05% |
| Danaher Corporation EC | $72.3M | 2.03% |
| Vertex Pharmaceuticals Incorporated EC | $71.2M | 2.00% |
| Stryker Corporation EC | $66.1M | 1.86% |
| Medtronic Public Limited Company EC | $64.3M | 1.80% |
| Elevance Health, Inc. EC | $47.9M | 1.34% |
| Regeneron Pharmaceuticals, Inc. EC | $45.2M | 1.27% |
| The Cigna Group EC | $42.8M | 1.20% |
| Boston Scientific Corporation EC | $40.7M | 1.14% |
| Hca Healthcare, Inc. EC | $35.3M | 0.99% |
| Edwards Lifesciences Corporation EC | $28.8M | 0.81% |
| Blackrock Funds Iii: Blackrock Cash Funds: Institutional; Sl Agency Shares STIV | $28.5M | 0.80% |
| Becton, Dickinson And Company EC | $27.6M | 0.78% |
| Idexx Laboratories, Inc. EC | $25.9M | 0.73% |
| Humana Inc. EC | $25.7M | 0.72% |
| Iqvia Holdings Inc EC | $23M | 0.64% |
| Agilent Technologies, Inc. EC | $22.9M | 0.64% |
| Waters Corporation EC | $21.8M | 0.61% |
| Natera, Inc. EC | $21.5M | 0.60% |
| Revolution Medicines, Inc. EC | $21.1M | 0.59% |
| Zoetis Inc. EC | $19.1M | 0.54% |
| Dexcom, Inc. EC | $18.8M | 0.53% |
| Illumina, Inc. EC | $18.3M | 0.51% |
| Ge Healthcare Technologies Inc. EC | $18.1M | 0.51% |
| Centene Corporation EC | $18M | 0.51% |
| Resmed Inc. EC | $18M | 0.51% |
| Veeva Systems Inc. EC | $17.9M | 0.50% |
| Biogen Inc. EC | $17.6M | 0.49% |
| Alnylam Pharmaceuticals, Inc. EC | $16.1M | 0.45% |
| Quest Diagnostics Incorporated EC | $15.1M | 0.42% |
| Labcorp Holdings Inc. EC | $14.9M | 0.42% |
| Royalty Pharma PLC EC | $14.2M | 0.40% |
| West Pharmaceutical Services, Inc. EC | $14M | 0.39% |
| Steris Public Limited Company EC | $13.1M | 0.37% |
| Tenet Healthcare Corporation EC | $12.8M | 0.36% |
| United Therapeutics Corporation EC | $12.6M | 0.35% |
| Insmed Incorporated EC | $12.4M | 0.35% |
| Guardant Health, Inc. EC | $12.1M | 0.34% |
| Viatris Inc. EC | $12M | 0.34% |
| Moderna, Inc. EC | $11.7M | 0.33% |
| Incyte Corporation EC | $11.6M | 0.33% |
| Zimmer Biomet Holdings, Inc. EC | $10.7M | 0.30% |
| Medline Inc. EC | $10.3M | 0.29% |
| Roivant Sciences Ltd EC | $9.74M | 0.27% |
| Neurocrine Biosciences, Inc. EC | $9.69M | 0.27% |
| Jazz Pharmaceuticals Public Limited Company EC | $8.86M | 0.25% |
| The Cooper Companies, Inc. EC | $8.28M | 0.23% |
| Bridgebio Pharma, Inc. EC | $7.94M | 0.22% |
| Baxter International Inc. EC | $7.88M | 0.22% |
Showing top 60 of 103 holdings.
Loading...
